ResMed Inc.Long
ResMed - low beta stock with solid balance sheet
We like low beta stocks, and ResMed is one of them.
Solid balance sheet and high profit margin.
Not cheap based on P/E, but justified by high RoE and high margins.
Solid balance sheet and high profit margin.
Not cheap based on P/E, but justified by high RoE and high margins.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.